Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Laheij, L. Rossum, A. Verbeek, J. Jansen (2003)
Helicobacter pylori Infection Treatment of Nonulcer Dyspepsia: An Analysis of Meta-AnalysesJournal of Clinical Gastroenterology, 36
R. Laheij, H. Straatman, J. Jansen, A. Verbeek (1998)
Evaluation of Commercially AvailableHelicobacter pylori Serology Kits: a ReviewJournal of Clinical Microbiology, 36
G. Sobala, J. Crabtree, J. Pentith, B. Rathbone, T. Shallcross, J. Wyatt, M. Dixon, R. Heatley, A. Axon (1991)
Screening dyspepsia by serology to Helicobacter pyloriThe Lancet, 338
M. Numans, Y. Graaf, N. Wit, R. Melker (2001)
How useful is selection based on alarm symptoms in requesting gastroscopy? An evaluation of diagnostic determinants for gastro-oesophageal malignancy.Scandinavian journal of gastroenterology, 36 4
N. Talley, M. Silverstein, L. Agréus, O. Nyrén, A. Sonnenberg, G. Holtmann (1998)
AGA technical review: Evaluation of dyspepsia ☆ ☆☆Gastroenterology, 114
R. Brignoli, Patrick Watkins, F. Halter (1997)
The Omega‐Project ‐ a comparison of two diagnostic strategies for risk‐ and cost‐oriented management of dyspepsiaEuropean Journal of Gastroenterology & Hepatology, 9
R. Laheij, J. Severens, J. Jansen, E. Lisdonk, A. Verbeek (1997)
Management in general practice of patients with persistent dyspepsia. A decision analysis.Journal of clinical gastroenterology, 25 4
B. Delaney, Scott Wilson, A. Roalfe, L. Roberts, V. Redman, A. Wearn, A. Briggs, F. Hobbs (2000)
Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary careThe Lancet, 356
M. Numans, Y. Graaf, N. Wit, R. Melker (2000)
How useful is selection by using alarm symptoms in requesting gastroscopy? An evalvation of diagnostic determinants for gastroesophageal malignancyGastroenterology, 118
P. Bytzer, J. Hansen, O. Muckadell (1994)
Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsiaThe Lancet, 343
A. Duggan, C. Elliot, K. Tolley, D. Whynes, C. Hawkey, R. Logan (2000)
Randomised controlled trial of four dyspepsia management strategies in primary care with 12 months follow-upGastroenterology, 118
P. Patel, M. Mendall, S. Khulusi, R. Lloyd, R. Jazrawi, J. Maxwell, T. Northfield (1995)
Prospective screening of dyspeptic patients by Helicobacter pylori serologyThe Lancet, 346
R. Laheij, J. Severens (1997)
Cost of endoscopy in economic evaluation.Gastroenterology, 113 6
R. Laheij, J. Severens, E. Lisdonk, A. Verbeek, J. Jansen (1998)
Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: a cost‐effectiveness analysisAlimentary Pharmacology & Therapeutics, 12
A. Lassen, F. Pedersen, P. Bytzer, O. Muckadell (2000)
Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trialThe Lancet, 356
Objective. Management of patients with dyspepsia remains controversial. No consensus has yet been reached concerning diagnostic and medical strategies. We conducted a randomized trial to assess the effectiveness of three management strategies for patients with uninvestigated persistent dyspeptic symptoms.Methods. A total of 199 patients presenting in primary care with dyspeptic symptoms (age 18–65 years, no alarming symptoms) were randomized to either empirical treatment with omeprazole and, in the case of symptomatic relapse, serological Helicobacter pylori infection testing plus eradication therapy (treat-and-test group), prompt upper gastrointestinal endoscopy (endoscopy group) or prompt upper gastrointestinal radiography (radiography group) followed by directed medical treatment. Symptoms, patients' satisfaction and use of resources were recorded during 6 months of follow-up.Results. Sixty-nine patients were assigned to the treat-and-test group, 64 to the radiography group and 66 to the endoscopy group. The median age was 44 years; 104 patients were male and 37% were H.pylori infected. A total of 170 patients (85%) returned the 6 months questionnaire. The numbers of patients with complete symptom relief in the treat-and-test group, endoscopy group and radiography group were 21, 16 and 15, respectively, at 3 months (P = 0.59), and 23, 13 and 12, respectively, at 6 months (P = 0.05). Twenty-two patients in the treat-and-test group underwent endoscopy or radiography. Two patients in the endoscopy group and four patients in the radiography group underwent more than one diagnostic test. The average medical cost per patient for the treat-and-test group was €276, for the endoscopy group €426 and for the radiography group €321, respectively.Conclusion. Empirical treatment followed by a test-and-eradicate strategy resulted in fewer diagnostic tests, more symptom relief and lower medical costs compared with prompt upper gastrointestinal radiography or endoscopy in the management of uninvestigated patients with persistent dyspeptic symptoms.
Family Practice – Oxford University Press
Published: Jun 1, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.